RE:RE:RE:RE:RE:RE:RE:RE:Piper Sandler Conf? It would be nice to test the proposition that they CAN build expectation. I think I could forgive them for doing it once! Haven't all the recent investor conferences been about building expectations?
Having said that I think you are about right, it's less common to announce that step, Maybe it happens more in going from pre-clinical to clinical, in some senses we are doing something similar in going from no program to a program.
I guess this means the cancer IND might already have been submitted if that didn't need the tweaking?
Maybe you didnt have this conservation with her but do you get the sense she's meeting her own expectations for the job from when she signed on for it?
SPCEO1 wrote: TH is adhering to the approach most drug company's take in not considering a submission of a trial protocol a material event. So, that is not an unusual approach. CYDY has the unusual approach of PR'ing everything almost to including when the CEO most recently trimmed his toenails!
The submission of the protocol is not a material event because it means nothing until the FDA/EMA say "proceed". When they get that good word, or if they get "desist" instead, that will be a material event. But I agree with your sentiment that in this particular case, a good argument can be made that this protocol submission is more material than most. My guess is we will get some indication at some point about its status just as we were told by the CEO last week that its submission was imminent.
One reason for not telling us when a protocol has been submitted (and this is true for all drug companies) is the company does not build up expectations they have to deal with later should the outcome not be favorable. In the case of TH with phase III NASH, however, there is no avoiding those expectations being built at this point.
scarlet1967 wrote: "She said if they put out some related PR maybe they would slide some mention of it into it but that they did not want to set a precedent for PR'ing a non-material piece of info like that. Basically, they don't want to become CYDY."
Why the submission is not a material event specially when there has been many doubts re validity of the program and delays?
They don't need to become CYDY but they certainly can show off the progress they are making including submission!
I would like to know how many companies out there would not inform their shareholders and other investors when they reach a milestone such as completion of a phase 3 application and submission of it?
This is not the way you promote your achievements and your business convincingly.
When does this public company understand they are one of hundreds and hundreds of companies investors can choose from so hiding your progress doesn't make sense if you want some attention.